免疫检查点阻断通过扩增效应 CD8⁺ T 细胞克隆增强淋巴细胞清除性化疗诱导的抗肿瘤免疫
Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Live-cell analyses with unsegmented images to study cancer cell response to modified T cell therapy.
Live-cell analyses with unsegmented images to study cancer cell response to modified T cell therapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
与癌细胞共培养的修饰T细胞的活细胞成像(LCI)通常用于量化T细胞的抗癌功能。LCI捕获的视频显示出复杂的多细胞行为表型,超越了简单的癌细胞荧光测量。
在此,我们开发了一种无监督分析工作流程,用于表征使用Incucyte成像平台生成的LCI数据。与大多数LCI分析不同,由于LCI视频的低时空分辨率和高水平的细胞间接触,我们避免进行细胞分割。相反,我们开发了识别全局聚集模式和局部细胞关键点的方法,以表征决定癌细胞对T细胞监视敏感性或逃逸的多细胞相互作用。
我们在来自四名供体的TCR T细胞上展示了我们的无分割活细胞行为分析(SF-LCBA)方法,这些T细胞具有不同比例的有益RASA2敲除细胞,以及与A375黑色素瘤细胞共培养中的不同效应细胞与靶细胞初始浓度。
我们发现不同的T细胞修饰影响多细胞聚集体形成的时空动态。特别是,我们表明在效应T细胞与靶癌细胞的高比率以及RASA2敲除T细胞的高滴度下,形成更少且更小的癌细胞聚集体。
我们的SF-LCBA方法在不适合细胞分割和追踪的数据集中识别、表征和追踪细胞聚集体的形成,为从LCI数据中对修饰T细胞治疗的细胞行为表型进行更具治疗相关性的测量打开了大门。
Live-cell imaging (LCI) of modified T cells co-cultured with cancer cells is commonly used to quantify T cell anti-cancer function. Videos captured by LCI show complex multi-cell behavioral phenotypes that go beyond simple cancer cell fluorescence measurements.
Here, we develop an unsupervised analysis workflow to characterize LCI data generated using the Incucyte imaging platform. Unlike most LCI analyses, we avoid cell segmentation due to the low spatiotemporal resolution of the LCI videos and high levels of cell-cell contact. Instead, we develop methods that identify global aggregation patterns and local cellular keypoints to characterize the multicellular interactions that determine cancer cell sensitivity to, or escape from, T cell surveillance.
We demonstrate our segmentation-free live-cell behavioral analysis (SF-LCBA) methods on TCR T cells from four donors with varying proportions of cells with a beneficial RASA2 knockout and effector-to-target initial concentrations in a co-culture with A375 melanoma cells.
We find that different T cell modifications affect the spatiotemporal dynamics of multicellular aggregate formation. In particular, we show that fewer and smaller cancer cell aggregates form at high ratios of effector T cells to target cancer cells and high titrations of T cells with RASA2 knockouts.
Our SF-LCBA method identifies, characterizes, and tracks cellular aggregate formation in datasets that are unsuitable for cell segmentation and tracking, opening the door to more therapeutically-relevant measurements of modified T cell therapy cell behavioral phenotypes from LCI data.
MEMBER ACCOUNT
登录成功会直接打开下一页。